Literature DB >> 24804308

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

Jonathan Himmelfarb, Katherine R Tuttle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24804308     DOI： 10.1056/NEJMc1400872

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Nrf2 at the heart of oxidative stress and cardiac protection.

Authors:  Qin M Chen; Anthony J Maltagliati
Journal:  Physiol Genomics       Date:  2017-11-29       Impact factor: 3.107

Review 2.  NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers.

Authors:  Laura Hurtado-Navarro; Diego Angosto-Bazarra; Pablo Pelegrín; Alberto Baroja-Mazo; Santiago Cuevas
Journal:  Antioxidants (Basel)       Date:  2022-04-28

3.  RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene.

Authors:  Peng Han; Zhiqiang Qin; Jingyuan Tang; Zhen Xu; Ran Li; Xuping Jiang; Chengdi Yang; Qianwei Xing; Xiaokang Qi; Min Tang; Jiexiu Zhang; Baixin Shen; Wei Wang; Chao Qin; Wei Zhang
Journal:  Oxid Med Cell Longev       Date:  2017-12-24       Impact factor: 6.543

Review 4.  Genetic polymorphisms associated with reactive oxygen species and blood pressure regulation.

Authors:  Santiago Cuevas; Van Anthony M Villar; Pedro A Jose
Journal:  Pharmacogenomics J       Date:  2019-02-06       Impact factor: 3.550

Review 5.  Nrf2 for cardiac protection: pharmacological options against oxidative stress.

Authors:  Qin M Chen
Journal:  Trends Pharmacol Sci       Date:  2021-07-28       Impact factor: 17.638

6.  Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths.

Authors:  Brad P Dieter; Radica Z Alicic; Rick L Meek; Robert J Anderberg; Sheryl K Cooney; Katherine R Tuttle
Journal:  Diabetes Spectr       Date:  2015-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.